|
PDE-9 inhibitor
|
P646350-2mg
|
≥99% |
1082743-70-1 |
2mg
|
¥ 1733.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PDE-9 inhibitor
|
P646350-10mg
|
≥99% |
1082743-70-1 |
10mg
|
¥ 3590.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PF-06751979
|
P646348-5mg
|
≥99% |
1818339-66-0 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PF-06751979
|
P646348-50mg
|
≥99% |
1818339-66-0 |
50mg
|
¥ 22000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PF-06751979
|
P646348-25mg
|
≥99% |
1818339-66-0 |
25mg
|
¥ 15000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PF-06751979
|
P646348-10mg
|
≥99% |
1818339-66-0 |
10mg
|
¥ 7500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PF-06751979
|
P646348-100mg
|
≥99% |
1818339-66-0 |
100mg
|
¥ 33000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Protease-Activated Receptor-1, PAR-1 Agonist
|
P646344-5mg
|
≥98% |
141136-85-8 |
5mg
|
¥ 1250.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Protease-Activated Receptor-1, PAR-1 Agonist
|
P646344-1mg
|
≥98% |
141136-85-8 |
1mg
|
¥ 500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Protease-Activated Receptor-1, PAR-1 Agonist
|
P646344-10mg
|
≥98% |
141136-85-8 |
10mg
|
¥ 1900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Peretinoin
|
P646343-5mg
|
Moligand™, ≥97% |
81485-25-8 |
5mg
|
¥ 827.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Peretinoin
|
P646343-100mg
|
Moligand™, ≥97% |
81485-25-8 |
100mg
|
¥ 4889.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PPAR agonist 1
|
P646339-1mg
|
|
539813-69-9 |
1mg
|
¥ 8900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PROTAC HSP90 degrader BP3
|
P646332-5mg
|
≥98% |
2669072-88-0 |
5mg
|
¥ 6500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PROTAC HSP90 degrader BP3
|
P646332-10mg
|
≥98% |
2669072-88-0 |
10mg
|
¥ 10200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PHD-1-IN-1
|
P646307-5mg
|
≥99% |
2009343-14-8 |
5mg
|
¥ 2260.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PHD-1-IN-1
|
P646307-50mg
|
≥99% |
2009343-14-8 |
50mg
|
¥ 11560.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PHD-1-IN-1
|
P646307-25mg
|
≥99% |
2009343-14-8 |
25mg
|
¥ 7220.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
PHD-1-IN-1
|
P646307-10mg
|
≥99% |
2009343-14-8 |
10mg
|
¥ 3610.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Py-BODIPY-NHS ester
|
P646237-5mg
|
≥98% |
201998-61-0 |
5mg
|
¥ 4800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Py-BODIPY-NHS ester
|
P646237-10mg
|
≥98% |
201998-61-0 |
10mg
|
¥ 7800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(Rac)-Pyrotinib
|
P646232-5mg
|
≥98% |
1246089-97-3 |
5mg
|
¥ 6500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(Rac)-Pyrotinib
|
P646232-50mg
|
≥98% |
1246089-97-3 |
50mg
|
¥ 29500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(Rac)-Pyrotinib
|
P646232-25mg
|
≥98% |
1246089-97-3 |
25mg
|
¥ 19500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |